Atlas Trials

A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy

Clinical trial NCT03474458 · TERMINATED

Trial details

NCT number
NCT03474458
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cardiac AL Amyloidosis
Start date
2019-02-11
Primary completion
2022-05-30
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.